event-trade登录编辑
RTTNews BiotechDoubao · 实盘不做把握 7/10不做原因:无增量信息
北京时间·🕒 发布 22:03:37·⟳ 抓取 22:15:16 +11m39s·⚡ 决策 09-14 22:17:10 +1m54s·43.0 天前

MiniMed就Medtronic分拆换股要约提交Form S-4,交易机制与时间表基本明牌

该消息是Medtronic已启动分拆后的SEC注册程序,条款、折价、股数、上限、税务条件和时间表均为交易文件层面的程序性披露;没有新的经营业绩、需求、订单或估值重估催化,事件方向不足以支持方向性短线交易。

📄 原文RTTNews Biotech↗ 原文
MiniMed Files Form S-4 In Connection With Medtronic Exchange Offer
Business Business Latest Headlines Top Stories Breaking News Earnings Biotech Investors Stock Alerts IPOs M&A Canadian…
不做 MiniMed(MMED.US)
S-4为已公布换股分拆的程序性文件,最终换股比例由10月VWAP决定;当前没有新增基本面edge,单边做多或做空均不等同于可执行的套利交易。
不做 Medtronic(MDT.US)
消息不改变Medtronic经营预期,剥离糖尿病业务属于预期内资本运作;条款未超预期,缺乏方向性短线催化。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

MiniMed提交S-4只是推进Medtronic已公布的换股式分拆,核心价格机制由10月上旬VWAP决定,当前报道不构成新增基本面惊喜。MMED与MDT均缺乏明确短线方向,故不做方向性交易。

🔎 新鲜度:最早出现 2026-09-14 · 扩散 low · price-in 风险 medium ↗

关键理由

  • 换股要约属资本结构和股东分配交易,7%折价已在报道中明示,最终比例尚未确定,当前无法形成稳定的单边正向或负向edge。
  • S-4提交是监管流程节点而非临床、业绩或订单催化,距要约到期仍有数周,短线更多受套利定价和两只股票相对价格约束。

主要风险

  • 若市场将分拆完成概率或税务免税意见重新定价,MMED与MDT可能出现相对价值波动,但这属于套利交易而非明确方向交易。
  • S-4审核、认购不足、上限触发或后续处置方式变化可能改变时间表和相对价格。

反向证据

  • 做多前查反向 · 来源 web · 日期 2026-09-14 · 影响 weakens
    当前输入未显示新增报价上调、要约提价、业绩上修或监管批准;S-4内容主要复述既有要约机制,未发现支持短线追多的新增惊喜。
    检索:Medtronic MiniMed exchange offer S-4 new terms surprise September 2026 原文 ↗

先例如何影响了这次决策

对本次决策的影响:先例不足与事件性质共同支持不做方向性ENTER;若未来参与,应按相对价值套利模型而非事件驱动多头/空头。

方向:未构建可用于定价的同类split-off/exchange offer先例;本案当前问题不是方向性基本面冲击,而是条款已明的相对价值套利。

涨幅量级:缺少同市场、同阶段且首发锚干净的对齐先例,不能据此设定短线止盈止损。

形态:程序性S-4提交通常不等同于新的并购惊喜;但未在本轮取得足够样本来量化见光死概率。

工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
  1. search_processed_events 成功 stock_tools HTTP · 19 ms
    {"result": "search_processed_events:agent query=`medtronic split-off minimed mmed exchange offer 225,361,295 shares | minimed form s-4 medtronic exchange offer | minimed separation medtronic 7% discount exchange ratio october 202`;结构化索引覆盖完整 72 小时;旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整),返回 0 条候选。未命中只表示这些 agen

原文全文

展开原文 · 9,847 字
MiniMed Files Form S-4 In Connection With Medtronic Exchange Offer
Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Biotech Daily Dose
MiniMed Files Form S-4 In Connection With Medtronic Exchange Offer
By
RTTNews Staff Writer
✉
Published:
9/14/2026 10:03 AM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
MiniMed (
MMED
) announced that it has filed a Form S-4 Registration Statement with the U.S. Securities and Exchange Commission (SEC) in connection with Medtronic's (
MDT
) exchange offer for up to 225,361,295 shares of MiniMed common stock, representing 80.1% of its outstanding shares.
Medtronic currently owns approximately 89.86% of MiniMed. Under the exchange offer, Medtronic shareholders will have the opportunity to exchange Medtronic ordinary shares for MiniMed common stock, subject to the terms and conditions of the offer.
If the exchange offer is oversubscribed, Medtronic intends to exchange an additional 27,452,053 MiniMed shares, representing its remaining interest, without extending the offer period.
Medtronic Exchange Offer
Medtronic launched the exchange offer to complete the separation of MiniMed, formerly its Diabetes
business
. MiniMed completed its initial public offering in March 2026, with Medtronic retaining approximately 90% ownership.
The exchange offer provides Medtronic shareholders with MiniMed shares at a 7% discount, subject to an upper limit of 4.5939 MiniMed shares for each Medtronic ordinary share tendered and accepted.
If the upper limit is not in effect, tendering shareholders are expected to receive approximately $107.53 of MiniMed common stock for every $100 of Medtronic ordinary shares tendered.
The final exchange ratio will be based on the arithmetic average of the daily volume-weighted average prices of Medtronic and MiniMed shares during the three trading days expected to be October 5, 6 and 7, 2026.
The exchange offer is currently expected to expire on October 9, 2026, unless extended or terminated.
Separation From Medtronic
Completion of the exchange offer is subject to certain conditions, including at least 112,680,647 MiniMed shares being issued in exchange for validly tendered Medtronic shares and receipt of an opinion that the transaction will generally qualify as tax-free for U.S. federal income tax purposes.
If the exchange offer is completed but not fully subscribed, Medtronic intends to divest any remaining MiniMed shares through a subsequent spin-off, split-off, debt-for-equity exchange or combination of these transactions.
If the exchange offer is completed as contemplated, Medtronic will no longer hold an equity stake in MiniMed.
Near-term Catalysts
The key upcoming catalyst is the completion of Medtronic's exchange offer, currently expected on October 9, 2026. Additional catalysts include the announcement of the final exchange ratio and the subsequent completion of MiniMed's separation from Medtronic.
The Form S-4 filing represents a further step toward MiniMed operating as a fully independent company, with Medtronic shareholders receiving an opportunity to exchange their shares for MiniMed common stock.
MMED has traded between $10.65 and $24.43 over the past year. The stock is currently trading at $22.06, down 1.96%.
MDT has traded between $73.31 and $106.33 over the past year. The stock is currently trading at $93.38, up 2.66%.
For comments and feedback contact: editorial@rttnews.com
Business News
Slide Shows
Biotech Stocks Facing FDA Decision In September 2026
Biotech Stocks Facing FDA Decision In August 2026
Biotech Stocks Facing FDA Decision In July 2026
Latest Updates on Middle East War
Futures Pointing To Initial Pullback On Wall Street
September 14, 2026 08:55 ET
U.S. Dollar Ticks Higher Amid Inflation Data Release, Expectations Of Reopening Of Strait Of Hormuz
September 11, 2026 17:00 ET
Crude Oil Slumps Amid Rising Expectations Of An End To Hormuz Crisis, Profit-taking
September 11, 2026 14:41 ET
U.S. Dollar Advances Amid Oil-Linked Inflation Concerns, PPI Data Release
September 10, 2026 17:00 ET
U.S. Stocks Show Significant Rebound As Crude Oil Pulls Back Sharply
September 11, 2026 16:13 ET
View More
Global Economics Weekly Update - Sep 07 – Sep 11, 2026
September 11, 2026 16:26 ET
Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.
View More Videos
RELATED NEWS
MiniMed Files Form S-4 In Connection With Medtronic Exchange Offer
Biotech Stocks At 52-Week Highs - MMED +10%, PLSE, SOLV, RPRX, APGE
Latest Updates on COVID-19
COVID-19 Sees Late-Summer Rise Across 49 US States
September 03, 2026 12:52 ET
COVID-19 Infections Rising In All 50 US States, CDC Data Shows
August 20, 2026 14:09 ET
COVID-19 Pandemic Linked To Higher Loneliness And Isolation In England, Study Finds
August 19, 2026 14:02 ET
View More
Editor's Pick
Most Read
Most Emailed
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Google To Invest 13 Bln Euros In Finland To Develop AI Infra, Clean Energy
September 09, 2026 09:11 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
Inditex H1 Profit Rises, Margin Flat, Backs FY26 Stable Margin View; Stock Drops
September 09, 2026 05:48 ET
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Orion180 Plans Up To $340 Mln IPO
September 09, 2026 08:04 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
HP Partners With Red Hat For AI Workloads; Shares Up
September 09, 2026 15:46 ET
Apple Unveils New AirPods And Apple Watch Lineup With Enhanced Audio, Health And AI Features
September 09, 2026 16:47 ET
Blackstone To Buy Flow Control Holdings From Audax For Undisclosed Terms
September 10, 2026 11:20 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Atlantic HPC Group To Go Public Via Aperture AC Merger
September 11, 2026 08:16 ET
SEALSQ H1 Loss Widens From Higher Expenses; Reaffirms FY26 Outlook
September 11, 2026 13:24 ET
Ageas Completes Sale Of 30.95% Maybank Ageas Stake To Maybank For EUR 1.1 Bln
September 11, 2026 01:43 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Holcim Invests In Cloud Cycle
September 09, 2026 03:16 ET
E79 Gold Mines Limited Full Year Sales Increase
September 09, 2026 01:00 ET
ASE Technology August Revenues Rise 34.6% Y-o-Y
September 09, 2026 03:18 ET
Everpure To Join S&P 500
September 09, 2026 01:09 ET
Victrex Plc Raises FY26 Underlying PBT View; Appoints Interim CFO; Stock Rises 12.8%
September 09, 2026 03:28 ET
Scientex Berhad Q4 Income Climbs
September 09, 2026 01:12 ET
Autohellas S.A. Reveals Fall In H1 Profit
September 09, 2026 03:33 ET
Chime To Acquire Stride Bank
September 09, 2026 01:26 ET
Sasol Agrees To Sell Nitrates Business To Enaex Africa; Retains 23% Stake
September 09, 2026 03:49 ET
Antin Infrastructure Partners SAS Profit Drops In H1
September 09, 2026 01:29 ET
TENPOS HOLDINGS Co Ltd. Reveals Retreat In Q1 Profit
September 09, 2026 05:03 ET
Vallourec, Aramco Ink Agreement For Supply Of Oil Country Tubular Goods
September 09, 2026 01:45 ET
Editors Pick
CPSC Recalls: 2.3 Mln Candy Bottles, Motorcycles, Dressers, Dual Fuel Ranges, Fire Spray Canisters
September 11, 2026 10:17 ET
Kroger Q2 Profit Rises, Backs FY26 Adj. Earnings View, Cuts Sales Growth Forecast; Stock Drops
September 11, 2026 07:40 ET
Macy's Stock Drops On Cautious Q3 View, Despite Positive Q2 Results, Raised FY26 Outlook
September 10, 2026 08:38 ET
Apple Unveils IPhone Duo, Its First Foldable IPhone
September 09, 2026 14:42 ET
Loading...

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。